In this discussion we will review the mechanism of Ivermectin against mutating SARS-COV-2.
These mechanisms are potential mechanisms observed in-silico, in-vitro, or in-vivo.
1. Ivermectin continues to bind with the Spike protein of the SARS-COV-2.
2. How ivermectin disrupts the viral replication by disrupting RdRp and 3-CTLP?
3. How ivermectin continues to help the cell produce interferons, regardless of the varaint?
4. How ivermectin continues to work on the nuclear factor kapp beta pathway?